ODE II Director Is Pulmonary & Allergy Division Chief Meyer
Executive Summary
Pulmonary & Allergy Drug Products Division Director Robert Meyer, MD, will become Office of Drug Evaluation II director effective June 16
You may also be interested in...
FDA Pulmonary Division acting director
Badrul Chowdhury, MD/PhD, appointed acting director of FDA's CDER Division of Pulmonary & Allergy Drug Products. Chowdhury, a team leader in the division for three years and a member of the Clarinex review team, succeeds Robert Meyer, MD, who became Office of Drug Evaluation II director in June (1"The Pink Sheet" June 3, p. 9)...
FDA Pulmonary Division acting director
Badrul Chowdhury, MD/PhD, appointed acting director of FDA's CDER Division of Pulmonary & Allergy Drug Products. Chowdhury, a team leader in the division for three years and a member of the Clarinex review team, succeeds Robert Meyer, MD, who became Office of Drug Evaluation II director in June (1"The Pink Sheet" June 3, p. 9)...
FDA ODE II Directorship Open; Kweder Tapped As Office Of New Drugs Deputy
FDA is looking to fill the Office of Drug Evaluation II director position following the appointment of Sandra Kweder, MD, to the Office of New Drugs as deputy director
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: